← Research library

Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic strokes

Randomized study in people · 2025

What was studied
490 stroke patients: 246 IV-first, 244 IM; double-dummy active comparison
Main finding
Compares routes of active Cortexin administration. Both groups received active drug; the placebo injections maintained masking.

mRS 0–2 at day 90 · 93.64% IV-form versus 86.50% IM-form

Reported findings and study design

490 stroke patients aged 30–80: IV-form Cortexin 246 versus IM-form Cortexin 244. Mean age 63.97 ± 8.5 years; 54.1% men, 45.9% women. Two ten-day courses with ten days between; follow-up 90 days. Both groups received active Cortexin.

Population or model 490 stroke patients: 246 IV-first, 244 IM; double-dummy active comparison

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
mRS 0–2 at day 9093.64% IV-form versus 86.50% IM-form
NIHSS reduction3.93 versus 3.72 points
MMSE increase4.11 versus 3.88 pointsp=0.249
Adverse events74 events in 60 IV-group patients versus 51 in 41 IM-group patientsp>0.05

The first course used 10 mg twice daily by the assigned active route with matching placebo by the other route; both then received IM Cortexin. This tests route/form equivalence, not efficacy versus no Cortexin.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • This is an active-route equivalence comparison, not evidence of benefit versus no Cortexin.
  • Noninferiority margin and full analysis require review; publication year is 2025 despite later indexing.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Randomized trialEnglish abstract

Fedin AI, Khairova EN, Artyukov OP, Timchenko LV, Bazhenova OA, Gaiduk NV, Zykov MV. Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic strokes Zh Nevrol Psikhiatr Im S S Korsakova 125(12):60-67. PMID 41524350

Study source ↗ · DOI 10.17116/jnevro202512512160 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards